GSA CAPITAL PARTNERS LLP - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of VBI VACCINES INC
ValueSharesWeighting
Q3 2022$441,000
-18.2%
624,438
-6.4%
0.06%
-28.4%
Q2 2022$539,000
+180.7%
667,059
+478.2%
0.08%
+211.5%
Q1 2022$192,000
-25.3%
115,365
+4.9%
0.03%
-18.8%
Q4 2021$257,000
-59.1%
110,011
-41.4%
0.03%
-54.9%
Q2 2021$629,000
+63.0%
187,760
+51.3%
0.07%
+10.9%
Q1 2021$386,000
+9.3%
124,118
-3.3%
0.06%
+10.3%
Q4 2020$353,000
+54.8%
128,322
+60.6%
0.06%
+52.6%
Q3 2020$228,00079,8770.04%
Other shareholders
VBI VACCINES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders